WELL CURVE

Does apple cider vinegar help you lose weight? What the trials show

A 2025 meta-analysis of 10 trials found small, short-term reductions in weight and BMI — but the studies were heterogeneous, and the viral single trial that fuelled the hype is one small study, not a settled result.

Pooled reduction in body measures with apple cider vinegar (standardised mean difference)BMI: 0.65; Body weight: 0.39; Waist circumference: 0.34012BMI0.65Body weight0.39Waist circumference0.34
Pooled reduction in body measures with apple cider vinegar (standardised mean difference)
GroupValue (value)
BMI0.65 (0.26 to 1.05)
Body weight0.39 (0.15 to 0.63)
Waist circumference0.34 (0.02 to 0.67)
Pooled reduction in body measures with apple cider vinegar (standardised mean difference) Random-effects meta-analysis of 10 randomised trials (789 adults) versus placebo; whiskers show 95% confidence intervals. Source: Nutrients

Apple cider vinegar (ACV) has a modest, real, but shaky evidence base for short-term weight loss [s1]. A 2025 meta-analysis of 10 randomised trials in 789 adults found small reductions in body weight, body-mass index and waist circumference, but the trials were heterogeneous and the effects were short-lived [s1]. It is not a substitute for the weight-loss drugs it is often marketed against, and the single trial that drove much of the recent excitement is one small, short study rather than a settled result [s1][s2].

The pooled evidence

The most complete picture comes from a 2025 systematic review and meta-analysis in Nutrients, which searched the literature up to March 2025 for randomised trials giving ACV for at least four weeks [s1]. Of 2,961 reports screened, 10 trials with 789 participants qualified [s1]. Pooling them with a random-effects model, daily ACV significantly reduced body weight (standardised mean difference −0.39, 95% CI −0.63 to −0.15, p=0.001), BMI (−0.65, 95% CI −1.05 to −0.26, p=0.001) and waist circumference (−0.34, 95% CI −0.67 to −0.02, p=0.04), while showing no significant effect on other body-composition measures [s1].

Two caveats sit inside those numbers. First, the heterogeneity was high — an I² of 62% for weight and 83% for BMI — meaning the trials disagreed substantially, so a single pooled figure oversimplifies [s1]. Second, the benefit was a short-term one: subgroup analyses found ACV helped when taken for up to 12 weeks, at a dose of about 30 mL a day, in adults who were overweight, obese or had type 2 diabetes, and the review framed it as an "adjunctive strategy for short-term weight management," not a durable fix [s1]. Reassuringly, excluding the studies at high risk of bias did not erase the weight and BMI effects [s1].

The viral single trial

Much of ACV's recent fame traces to one 2024 trial in BMJ Nutrition, Prevention & Health [s2]. It randomised 120 overweight and obese Lebanese adolescents and young adults to 5, 10 or 15 mL of ACV or a placebo for 12 weeks, measuring them at weeks 0, 4, 8 and 12 [s2]. It reported significant reductions in weight, BMI, waist and hip circumference and body-fat ratio, along with lower blood glucose, triglycerides and cholesterol, and no significant adverse effects [s2].

Those are striking claims — and they are the reason to read the pooled evidence first. This is a single, relatively small trial in a narrow age group, and its broad, uniformly positive results outrun what the wider trial base supports [s1][s2]. When a lone study reports a supplement improving nearly every measure at once, the honest reading is caution until it is replicated, not a headline.

What about blood sugar

The metabolic angle has slightly firmer, if still preliminary, support in specific groups. A 2026 randomised trial in Scientific Reports tested ACV as an add-on in 94 women with polycystic ovary syndrome and metabolic syndrome who were already taking metformin at 1,500 mg a day [s3]. Resolution of metabolic syndrome was significantly more common with ACV (74.5%) than placebo (40.4%, p=0.001), with a significant reduction in insulin resistance (p=0.01) [s3]. That is a real signal, but it describes vinegar as an adjunct to a prescribed drug in one clinical population — not evidence that ACV alone reorders a healthy person's metabolism.

The trade-offs

ACV is acetic acid, and it is not consequence-free at the doses enthusiasts reach for. A 2024 case report in ACG Case Reports Journal described an 84-year-old woman who developed acute pancreatitis possibly linked to a newly started ACV weight-loss supplement, and noted how thinly the risks of such loosely regulated products are documented [s4]. A single case cannot establish cause, but it is the kind of signal that the confident packaging never mentions.

Bottom line

The claim survives, narrowed sharply. High-quality pooling suggests ACV can produce a small, short-term reduction in weight and BMI in people carrying excess weight, most clearly around 30 mL a day for up to 12 weeks — a modest adjunct, not a transformation [s1]. The metabolic effects are promising in specific groups and the "natural Ozempic" framing oversells all of it, a pattern this site has traced before with berberine and in the order you eat foods in. None of this is medical advice.

Sources

Sources

  1. Effect of Apple Cider Vinegar Intake on Body Composition in Humans with Type 2 Diabetes and/or Overweight: A Systematic Review and Meta-Analysis of Randomized Controlled Trials — Nutrients , September 19, 2025
  2. Apple cider vinegar for weight management in Lebanese adolescents and young adults with overweight and obesity: a randomised, double-blind, placebo-controlled study — BMJ Nutrition, Prevention & Health , March 12, 2024
  3. Adjunctive effects of apple cider vinegar on metabolic syndrome and insulin resistance in polycystic ovary syndrome patients receiving metformin: a randomized clinical trial — Scientific Reports , May 29, 2026
  4. Unveiling a Sour Truth: Acute Pancreatitis Linked to Apple Cider Vinegar Supplement — ACG Case Reports Journal , September 5, 2024

More on

Related coverage